Catheter-related bladder discomfort
Conditions
Interventions
Trial Group:Electro-acupuncture therapy: Four pairs of acupoints (Taixi, Shuiquan, Hegu, Sanyinjiao) were selected, with anatomical positioning based on the national standard 'Names and Locations of A
Sham Group:Sham acupuncture: After routine disinfection of the local skin at four acupoints, adhesive pads were placed on the sites. A specially designed blunt-tipped 1-cun needle was inserted through
Sponsors
Xiangya Hospital Central South University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Undergoing elective non-cardiac surgery under general anesthesia 2. Aged 18 to 60 years 3. Body Mass Index (BMI) between 18 and 30 4. Preoperative ASA Physical Status Classification I to III 5. Patients who complain of catheter-related bladder discomfort after tracheal extubation in the PACU 6. Fully understand the trial protocol and objectives and have signed the informed consent form
Exclusion criteria
Exclusion criteria: 1. Preoperative history of bladder disease (neurogenic bladder, bladder stones, bladder diverticulum, overactive bladder) or urinary tract infection 2. Patients who have undergone bladder or urethral surgery (e.g., transurethral resection of the prostate) within the past 3 months 3. Patients with central or peripheral neurological disorders (e.g., dementia, Parkinson's disease, spinal cord injury, multiple sclerosis) 4. History of long-term use of anticholinergic drugs, analgesics (e.g., opioids, gabapentin), or sedatives 5. Coagulation dysfunction or presence of infection, scars at the acupuncture site 6. Patients experiencing agitation or delirium upon emergence from anesthesia in the PACU, making cooperation difficult 7. Complicated by severe cardiovascular or cerebrovascular diseases (e.g., myocardial infarction, unstable angina, stroke with sequelae) 8. Patients with a cardiac pacemaker 9. Inability to tolerate acupoint stimulation 10. Concurrent participation in other clinical studies 11. Pregnancy or breastfeeding 12. Presence of other conditions deemed by the investigator as unsuitable for participation in this clinical study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of CRBD at T1 (5 minutes post-intervention); | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analog Scale (VAS) for urethral and surgical site pain at T1, T2, and T3;Richmond Agitation-Sedation Scale (RASS);Hemodynamic parameters including non-invasive blood pressure (NIBP), pulse oximetry (SpO2), and heart rate (HR) at T0, T1, T2, and T3;Use of rescue medication (oxycodone);Incidence of adverse events related to electroacupuncture;Use of other medications during the study period; | — |
Countries
China
Contacts
Public ContactXia Pingping
Department of Anesthesiology, Xiangya Hospital, Central South University
Outcome results
None listed